Annual ROE
-28.35%
+5.96%+17.37%
31 December 2023
Summary:
Akero Therapeutics annual return on equity is currently -28.35%, with the most recent change of +5.96% (+17.37%) on 31 December 2023. During the last 3 years, it has risen by +2.27% (+7.41%). AKRO annual ROE is now -117.32% below its all-time high of 163.69%, reached on 31 December 2018.AKRO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-32.52%
-2.96%-10.01%
30 September 2024
Summary:
Akero Therapeutics quarterly return on equity is currently -32.52%, with the most recent change of -2.96% (-10.01%) on 30 September 2024. Over the past year, it has dropped by -6.41% (-24.55%). AKRO quarterly ROE is now -119.87% below its all-time high of 163.69%, reached on 31 December 2018.AKRO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKRO ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.4% | -24.6% |
| 3 y3 years | +7.4% | +23.4% |
| 5 y5 years | -117.3% | +70.8% |
AKRO ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +52.4% | -24.6% | +51.1% |
| 5 y | 5 years | -117.3% | +52.4% | -24.6% | +70.8% |
| alltime | all time | -117.3% | +52.4% | -119.9% | +96.3% |
Akero Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -32.52%(+10.0%) |
| June 2024 | - | -29.56%(+6.4%) |
| Mar 2024 | - | -27.78%(-6.6%) |
| Dec 2023 | -28.35%(-17.4%) | -29.74%(+13.9%) |
| Sept 2023 | - | -26.11%(-10.0%) |
| June 2023 | - | -29.01%(-27.1%) |
| Mar 2023 | - | -39.77%(-14.4%) |
| Dec 2022 | -34.31%(-42.4%) | -46.44%(-22.8%) |
| Sept 2022 | - | -60.13%(-9.6%) |
| June 2022 | - | -66.51%(+9.3%) |
| Mar 2022 | - | -60.85%(+25.9%) |
| Dec 2021 | -59.59% | -48.34%(+13.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -42.48%(+12.9%) |
| June 2021 | - | -37.63%(+2.1%) |
| Mar 2021 | - | -36.84%(-10.8%) |
| Dec 2020 | -30.62%(-9.9%) | -41.30%(+1.1%) |
| Sept 2020 | - | -40.87%(-14.8%) |
| June 2020 | - | -47.97%(+30.9%) |
| Mar 2020 | - | -36.65%(+4.7%) |
| Dec 2019 | -33.99%(-120.8%) | -34.99%(-68.6%) |
| Sept 2019 | - | -111.49%(-22.3%) |
| June 2019 | - | -143.51%(-83.7%) |
| Mar 2019 | - | -877.83%(-636.3%) |
| Dec 2018 | 163.69% | 163.69% |
FAQ
- What is Akero Therapeutics annual return on equity?
- What is the all time high annual ROE for Akero Therapeutics?
- What is Akero Therapeutics annual ROE year-on-year change?
- What is Akero Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Akero Therapeutics?
- What is Akero Therapeutics quarterly ROE year-on-year change?
What is Akero Therapeutics annual return on equity?
The current annual ROE of AKRO is -28.35%
What is the all time high annual ROE for Akero Therapeutics?
Akero Therapeutics all-time high annual return on equity is 163.69%
What is Akero Therapeutics annual ROE year-on-year change?
Over the past year, AKRO annual return on equity has changed by +5.96% (+17.37%)
What is Akero Therapeutics quarterly return on equity?
The current quarterly ROE of AKRO is -32.52%
What is the all time high quarterly ROE for Akero Therapeutics?
Akero Therapeutics all-time high quarterly return on equity is 163.69%
What is Akero Therapeutics quarterly ROE year-on-year change?
Over the past year, AKRO quarterly return on equity has changed by -6.41% (-24.55%)